AsedaSciences adds Wepredic’s cosmetics safety tests to 3RnD platform

AsedaSciences and Wepredic have struck a strategic sales and marketing agreement that brings Eurosafe’s non-animal cosmetics safety screening services into the 3RnD platform. The deal also gives Wepredic sales and marketing rights for 3RnD in France, Belgium and Switzerland, expanding access to integrated safety assessment tools for cosmetics companies.

Why it matters: - The agreement gives cosmetics developers a single place to connect non-animal safety data with broader chemical intelligence. - The move could help companies make earlier decisions on ingredient selection, concentration and formulation without relying on animal testing. - The partnership expands access to integrated New Approach Methodologies, or NAMs, across key European cosmetics markets.

What happened: - AsedaSciences announced a Strategic Sales and Marketing Agreement with Wepredic. - The companies said the deal integrates selected Eurosafe screening services into the 3RnD cloud-based toxicity intelligence platform. - Wepredic will also act as a commercial sales and marketing partner for 3RnD in France, Belgium and Switzerland. - The announcement was made Sept. 29, 2026. - AsedaSciences is based in Schindellegi, Schwyz, Switzerland.

The details: - The integrated Eurosafe services include skin permeation, dermal absorption and skin sensitization assessments. - The offering is designed to support safety evaluation of cosmetic ingredients and inform concentrations of use based on intended use and exposure conditions. - 3RnD also includes Biomimetic Chromatography, which can provide insights relevant to cell permeability and compound distribution. - 3RnD also supports GPCR screening, which can assess interactions with G protein-coupled receptors expressed by skin cells. - The platform centralizes, connects and visualizes data from multiple methods instead of leaving test results in isolation. - Wepredic brings safety assessment products and services through its Biopredic, Eurosafe and Starlight brands. - Eurosafe provides regulatory toxicology expertise, in vitro testing and clinical studies for cosmetic ingredients and finished products.

Between the lines: - The deal points to a broader shift in cosmetics safety toward combining multiple human-relevant methods in one decision-support workflow. - AsedaSciences is using the partnership to deepen the 3RnD ecosystem with specialized testing services, while Wepredic gains a distribution role for the platform. - The arrangement also gives both companies a stronger foothold in a market where regulatory and consumer pressure continue to favor non-animal approaches. - Brad Calvin, CEO of AsedaSciences, said connected data from dermal absorption, skin permeation, sensitization and other human-relevant methods can create a more comprehensive evidence base for safer chemical design. - Christophe Chesné, CEO of Wepredic, said the combined approach helps customers make more informed decisions earlier in R&D.

What's next: - Wepredic will market 3RnD in France, Belgium and Switzerland. - AsedaSciences will offer selected Eurosafe services through 3RnD as part of the expanded platform offering. - The companies are positioning the collaboration as a step toward more connected, human-relevant cosmetics safety assessment.